References
- Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol 1998; 9: 717-20. PMID: 9739436
- Shea L, Liu J, Cashen A. Prognostic significance of [18F]fluorodeoxyglucosepositron emission tomography in peripheral T-cell lymphoma treated with stem cell transplantation: a retrospective analysis. Leuk Lymphoma 2015; 56: 256-9. 10.3109/10428194.2014.914194
- Park S, Ko YH. Peripheral T cell lymphoma in Asia. Int J Hematol 2014; 99: 227-39. 10.1007/s12185-014-1520-3
- Yi S, An G, Qi J, Zou D, Zhao Y, Zhang P, et al. The significance of bone marrow involvement in aggressive lymphomas: A retrospective comparison of clinical outcomes between peripheral T cell lymphoma and diffuse large B cell lymphoma in China. Acta Haematol 2010; 124: 239-44. 10.1159/000321544
- Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Brière J, Haioun C, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA). Blood 1998; 92: 76-82. PMID: 9639502
- Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol 2016; 34: 963-71. 10.1200/JCO
- Lim ST, Hee SW, Quek R, Lim LC, Yap SP, Loong EL, et al. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis. Eur J Haematol 2008; 80: 55-60. 10.1111/j.1600-0609.2007.00978.x
- Lee HJ, Im JG, Goo JM, Kim KW, Choi BI, Chang KH, et al. Peripheral T-cell lymphoma: spectrum of imaging findings with clinical and pathologic features. Radiographics 2003; 23: 7-26. 10.1148/rg.231025018
- Otero HJ, Jagannathan JP, Prevedello LM, Johnston CJ, Ramaiya NH, Van den Abbeele AD, et al. CT and PET/CT findings of T-cell lymphoma. Am J Roentgenol 2009; 193: 349-58. 10.2214/AJR.08.1398
- Choi JW, Kim SS, Kim EY, Heran M. Peripheral T-cell lymphoma in the neck: CT findings of lymph node involvement. Am J Neuroradiol 2006; 27: 107982. PMID: 16687547
- Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. Am J Roentgenol 1997; 168: 1439-43. 10.2214/ajr.168.6.9168704
- Weber AL, Rahemtullah A, Ferry JA. Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation. Neuroimaging Clin N Am 2003; 13: 371-92. 10.1016/S1052-5149(03)00039-X
- Zhou C, Duan X, Lan B, Liao J, Shen J. Prognostic CT and MR imaging features in patients with untreated extranodal non-Hodgkin lymphoma of the head and neck region. Eur Radiol 2015; 25: 3035-42. 10.1007/s00330-015-3708-1
- Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, et al. Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 2005; 106: 3785-90. 10.1182/blood-2005-05-2056
- Opdam FJ, Kamp M, de Bruijn R, Roos E. Jak kinase activity is required for lymphoma invasion and metastasis. Oncogene 2004; 23: 6647-53. 10.1038/sj.onc.1207887
- Mahadevan D, Spier C, Della Croce K, Miller S, George B, Riley C, et al. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Mol Cancer Ther 2005; 4: 1867-79. 10.1158/1535-7163 MCT-05-0146
- Pileri SA, Piccaluga PP. New molecular insights into peripheral T cell lymphomas. J Clin Invest 2012; 122: 3448-55. 10.1172/JCI61205
- Ruddell A, Mezquita P, Brandvold KA, Farr A, Iritani BM. B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis. Am J Pathol 2003; 163: 2233-45. 10.1016/S0002-9440(10)63581-X
- Ruddell A, Harrell MI, Furuya M, Kirschbaum SB, Iritani BM. B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia 2011; 13: 748-57. PMID: 21847366
- Rodriguez M, Rehn SM, Nyman RS, Sundström JC, Ahlström H, Glimelius BL. CT in malignancy grading and prognostic prediction of non-Hodgkin’s lymphoma. Acta Radiol 1999; 40: 191-7. PMID: 10080733
- Singh V, Singh MP, Singh SM. Cell density-dependent alterations in tumorigenic potential of a murine T-cell lymphoma: implication in the evolution of multidrug resistance in tumor cells. Anticancer Drugs 2008; 19: 793-804. 10.1097/CAD.0b013e32830ce4f5
- Cardesa-Salzmann TM, Colomo L, Gutierrez G, Chan WC, Weisenburger D, Climent F, et al. High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy. Haematologica 2011; 96: 996-1001. 10.3324/haematol.2010.037408
- Hopper KD, Diehl LF, Cole BA, Lynch JC, Meilstrup JW, McCauslin MA. The significance of necrotic mediastinal lymph nodes on CT in patients with newly diagnosed Hodgkin disease. Am J Roentgenol 1990; 155: 267-70. 10.2214/ajr.155.2.2115249
- Saito A, Takashima S, Takayama F, Kawakami S, Momose M, Matsushita T. Spontaneous extensive necrosis in non-Hodgkin lymphoma: prevalence and clinical significance. J Comput Assist Tomogr 2001; 25: 482-6. PMID: 11351202
- Adams HJ, de Klerk JM, Fijnheer R, Dubois SV, Nievelstein RA, Kwee TC. Prognostic value of tumor necrosis at CT in diffuse large B-cell lymphoma. Eur J Radiol 2015; 84: 372-7. 10.1016/j.ejrad.2014.12.009
- Kim SJ, Choi CW, Mun YC, Oh SY, Kang HJ, Lee SI, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL). BMC Cancer 2011; 11: 321-32. 10.1186/1471-2407-11-321
- Raanani P, Shasha Y, Perry C, Metser U, Naparstek E, Apter S, et al. Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann Oncol 2006; 17: 117-22. 10.1093/annonc/mdj024
- la Fougère C, Hundt W, Bröckel N, Pfluger T, Haug A, Scher B, et al. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 2006; 33: 1417-25. 10.1007/s00259-006-0171-x
- Fueger BJ, Yeom K, Czernin J, Sayre JW, Phelps ME, Allen-Auerbach MS. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin’s lymphoma. Mol Imaging Biol 2009; 11: 269-74. 10.1007/s11307-009-0200-9
- Ricard F, Giammarile F, Tychyj-Pinel C, Houzard C, Decullier E, Chateau F, et al. PET-CT and diagnostic CT: the synergy of metabolic and morphological data in onco-haematology. Diagn Interv Imaging 2014; 95: 55-62. 10.1016/j.diii.2013.07.008
- Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, et al. Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma. BMC Cancer 2015; 15: 198. 10.1186/s12885-015-1193-1
- Cottereau AS, Becker S, Broussais F, Casasnovas O, Kanoun S, Roques M, et al. Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL). Ann Oncol 2016; 27: 719-24. 10.1093/annonc/mdw011